Mitchell Goldman

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• AstraZeneca (United States)13.6%
• Inserm9.4%
• German Center for Lung Research7.3%
• Imperial College London7%
• AstraZeneca (Sweden)6.9%
• McMaster University6.9%
• Other48.9%

Fields

• Medicine94.7%
• Immunology and Microbiology2.3%
• Biochemistry, Genetics and Molecular Biology1.3%
• Health Professions0.4%
• Pharmacology, Toxicology and Pharmaceutics0.2%
• Computer Science0.2%
• Other0.9%

Topics

• Asthma and respiratory diseases27.7%
• Chronic Obstructive Pulmonary Disease (COPD) Research8.8%
• Respiratory and Cough-Related Research8.6%
• Antifungal resistance and susceptibility8.5%
• Fungal Infections and Studies7.3%
• IL-33, ST2, and ILC Pathways6.1%
• Other32.8%